Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

VivoSim Labs

Tracked across 4 events · 25 articles · First seen Jun 29, 2026 · Last active Aug 06, 2026

Sentiment
46
Attention
4
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 75
Tech
Impact: VivoSim Labs announced data demonstrating the high predictive power of its AI-enabled NAMkind Liver and NAMkind GI platforms for preclinical safety testing, which is expected to increase demand for its services and improve its market position.
Jun 29, 2026 · 7 articles
1 10
Business
Impact: VivoSim Labs is the issuer of the private placement, raising $4 million for working capital. The offering includes shares and warrants at $0.85 per share, with existing warrants amended to the same price.
Jul 16, 2026 · 6 articles
2 30
Business
Impact: VivoSim achieved its first commercial sales in China, validating its channel strategy and opening a significant new market. The company expects China to become a meaningful revenue contributor.
Jul 21, 2026 · 6 articles
2 70
Regulatory
Impact: VivoSim regained Nasdaq compliance, received milestone payments, and completed financing, boosting its cash position and reducing delisting risk.
Aug 06, 2026 · 6 articles
ERGEN INTELLIGENCE
Track VivoSim Labs live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.